TAT and breast cancer: When membrane-permeant peptides were added to the culture media of breast cancer cells, a specific decrease in cell proliferation was detected in high VANGL2-expressing cells (SUM149 and HCC1806) with FITC-Tat-p62DN peptide, but not with the control peptide (Supplementary Fig. 7).